Irreversible Electroporation (IRE) for the treatment of focal liver, kidney and lung cancer ablation: a pilot study
Not Applicable
Completed
- Conditions
- Focal tumours of the liverFocal tumours of the lungFocal tumours of the kidneyCancer - KidneyCancer - LiverCancer - Lung - Small cell
- Registration Number
- ACTRN12611000937910
- Lead Sponsor
- The Alfred Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Ages 35-85 years, Signed informed consent, Failed conventional treatment, Ability to visualize cancer foci adequately on imaging.
Exclusion Criteria
Patients not deemed suitable for ablation procedure.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method